Gw Pharmaceuticals

7 results

Bank of America, PayPal and Netflix post their reults on Wednesday. Photograph: Andrew Harrer/Bloomberg
Your business week: all the results, indicators and meetings

MONDAY Results: GW Pharmaceuticals. Indicators: Irish trade statistics (Jul); Euro-zone industrial production (Aug). Meetings: Brexit: Are We in (...)

A major push towards legalisation here may come from US and Canadian cannabis corporations who view Ireland as a jump-off point into the EU market. Photograph: Rungroj Yongrit/EPA
Roll up, roll up: capitalism will drive cannabis legalisation in Ireland

It is inevitable that cannabis will be legalised in Ireland in the coming years. It may take five years or even longer for the prohibition to be fully(...)

In the aftermath of the Disclosures Tribunal and recent amendments to Ireland’s whistleblowing laws, “it is understandable that Irish employers are seeking clarity on how to deal with protected disclosures in the workplace”
Business This Week: results, indicators and meetings

MONDAY (November 26th) Results: Fusion Antibodies. Indicators: UK mortgage approvals (Oct); German business climate, current conditions and expectat(...)

KBC Bank Ireland is due to release results on Thursday. Photograph: Bryan O’Brien
This Week: Results from KBC, Glanbia and Kerry Group

MONDAY Results: Marriott International, Sotheby’s. Indicators: euro-zone retail PMI (Jul); UK car sales (Jul); German factory orders (Jun), constr(...)

A leaf of the cannabis plant. Photograph: Thinkstock
Medical marvel: the uses of cannabis continue to grow

Spare a thought for Bert Trautmann, a goalkeeper who suffered two cracked vertebrae in his neck while playing for Manchester City in the 1956 FA Cu(...)

Allied Irish Banks lent €1 million to developer Michael O’Flynn to buy racehorses in January 2008. Photograph: Courtpix
Seen & Heard: AIB lent O’Flynn €1m to buy horses

€1m racehorses Allied Irish Banks lent €1 million to developer Michael O’Flynn to buy racehorses in January 2008, just months before the credit crunch(...)

Bubble fears grow amid glut of IPOs in the US by early-stage biotechs

The fastest start to a year for US biotech initial public offerings is stoking fears of a bubble amid fears investors are taking increasing risks on c(...)